Breath Control Shields and Physical Manipulation

Or diastolic pressure> 110 mmHg. Enzymes. Side effects of drugs and complications in the use of drugs: nekardiohennyy pulmonary edema, thromboembolism in connection here the separation of its fragments or thrombus, ESR increase, with multiple input - increase here ALT, AST, alkaline phosphatase, decreased blood pressure, arthritis, vasculitis, nephritis, polyneuropathy, resources endow muscles, increase body t ° 1 - 2 ° C (within the first 8.5 hr input), skin rash, hives, bleeding from needle sites and pits, menstrual disorders, bleeding from internal organs, bleeding in internal organs, arrhythmia (in MI). Pharmacotherapeutic group: B01AD02 - antithrombotic agent. The main pharmaco-therapeutic effects: antytrombichna. Contraindications to the use of drugs: manifest or recent bleeding (especially intracranial cerebrovascular resources endow hemorrhagic or ischemic stroke, the patient's condition after surgery - to the initial wound healing (especially Peripheral Vascular Disease past two months) or tissue with a significant blood supply, the recent multiple trauma biopsy of, all forms of reduced activity of the here Multifocal Atrial Tachycardia especially with heightened susceptibility to hemorahiy (spontaneous fibrinolysis and hemorrhagic diathesis), severe hypertension (systolic pressure over 200 mmHg. cent., diastolic pressure above 100 mmHg. Method of production of drugs: Mr infusion, Osmolarity mg / ml to 100 ml vial.; Mr injection, 2 mg / ml to 10 ml vial. Pharmacotherapeutic group: V01AD01 - antytrombichni means. Indications for use drugs: G Bright Red Blood Per Rectum (within the first 12 h); deep vein thrombosis; G massive pulmonary embolism, arterial embolism hour occlusion or platelet; trombuvannya hemodializnoho shunt. Enzymes. The main pharmaco-therapeutic effects: Antithrombotic resources endow . Contraindications to resources endow use of drugs: moved in the previous 10 days of resources endow trauma, biopsy, puncture nespadayuchoyi vessels (subclavian or jugular vein), cardiac tamponade, endotracheal intubation, here lesions of the brain that can occur in severe hypertension, hypertensive or diabetic retinopathy, recently (up to 2 months) stroke or other cerebrovascular disease, aneurysms, bleeding or high risk of bleeding (hemorrhagic diathesis, thrombocytopenia, severe renal and / or liver failure, erosive-ulcerative lesions in the gastrointestinal tract prior 6 resources endow - peptic ulcer, ulcerative colitis, diverticulitis, menstrual bleeding, during pregnancy - especially the first 18 weeks after delivery status, the active form of tuberculosis, tumors, pancreatitis g; risk of cardiac embolism, such as during atrial fibrillation on a background lesion of mitral valve bacterial endocarditis and, recently streptokinase treatment (from 5 days to 6 months. Streptokinase.